文献速递认知障碍与痴呆

带状疱疹发病与痴呆风险:一项基于丹麦人群的队列研究

Incident Herpes Zoster and Risk of Dementia: A Population-Based Danish Cohort Study.
PubMed 文献 · Neurology · 2022-08-15

该研究利用1997-2017年丹麦全国登记数据,纳入247,305例带状疱疹患者和1,235,890名匹配对照,评估带状疱疹与痴呆的关联。结果显示带状疱疹患者第一年痴呆风险比0.98(95%CI 0.92-1.04),此后为0.93(95%CI 0.90-0.95),带状疱疹未增加痴呆风险,反而略有降低;中枢神经系统感染亚组风险比1.94(95%CI 0.78-4.80),但该并发症归因分数仅0.014%。

要点

  • 带状疱疹患者随访第一年痴呆风险比0.98(95%CI 0.92-1.04),此后为0.93(95%CI 0.90-0.95),未增加痴呆风险。
  • 随访结束时带状疱疹组9.7%诊断痴呆,匹配对照组10.3%。
  • 中枢神经系统感染亚组痴呆风险比1.94(95%CI 0.78-4.80),该并发症归因分数估计为0.014%。

核心结论

  • 带状疱疹与痴呆风险增加无关,反而观察到风险小幅降低,该发现原因不明,应考虑系统误差。
  • 中枢神经系统受累患者痴呆相对风险增加近2倍,但该罕见并发症的归因分数估计为0.014%。
  • 作者认为对老年人普遍接种水痘-带状疱疹病毒疫苗不太可能降低痴呆风险。

研究设计与样本

  • 基于丹麦全国关联登记数据的队列研究,纳入1997-2017年年龄≥40岁的带状疱疹患者及按性别和出生年5:1匹配的一般人群对照。
  • 通过社区处方记录和医院诊断识别带状疱疹和痴呆。
  • 采用Cox回归计算混杂因素调整的风险比及95%CI,并比较混杂因素逆概率加权后的痴呆累积发病率。

主要发现

  • 共纳入247,305例带状疱疹患者和1,235,890名匹配对照,中位年龄64岁,女性占61%。
  • 随访第一年全因痴呆风险比为0.98(95%CI 0.92-1.04),此后为0.93(95%CI 0.90-0.95),均为带状疱疹患者与匹配对照比较。
  • 随访结束时带状疱疹患者9.7%诊断痴呆,匹配对照为10.3%。
  • 亚组分析未观察到长期痴呆风险增加,中枢神经系统感染亚组风险比为1.94(95%CI 0.78-4.80)。
  • 以阿尔茨海默病为结局的分析显示类似结果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出该发现原因不明,应考虑系统误差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Herpes zoster (HZ) is caused by reactivation of the neurotrophic varicella-zoster virus (VZV). Zoster may contribute to development of dementia through neuroinflammation, cerebral vasculopathy, or direct neural damage, but epidemiologic evidence is limited. We used data from linked nationwide Danish registries to conduct a cohort study of the association between zoster and dementia during 1997-2017. As secondary aims, we examined whether associations were more pronounced for zoster involving cranial nerves (mainly ophthalmic zoster) or the CNS and Alzheimer disease as an outcome. METHODS: We included people aged ≥40 years with zoster and a general population comparison cohort matched 5:1 by sex and birth year. We identified zoster and dementia in the registries using prescription records in the community and hospital diagnoses. We used Cox regression to compute confounder-adjusted hazard ratios (HRs) with 95% CIs for dementia associated with zoster during 0-1 year and 1-21 years of follow-up. We compared the cumulative incidence of dementia, inverse probability weighted for confounders. RESULTS: The study included 247,305 people with zoster and 1,235,890 matched general population comparators (median age 64 years; 61% female). The HR of all-cause dementia was 0.98 (95% CI 0.92-1.04) during the first year and 0.93 (95% CI 0.90-0.95) thereafter in people with zoster vs matched comparators. Dementia was diagnosed in 9.7% of patients with zoster and 10.3% of matched comparators by the end of follow-up. We observed no increased long-term risk of dementia in subgroup analyses, except possibly in people with CNS infection (HR 1.94; 95% CI 0.78-4.80). Analyses of Alzheimer disease as a separate outcome showed similar results. DISCUSSION: HZ is not associated with an increased risk of dementia, and contrary to expectation, we found a small decrease in the risk. The explanation for this finding is unclear, and systematic errors should be considered. Patients with CNS involvement had an almost 2-fold increased relative risk of dementia. The population attributable fraction of dementia due to this rare complication is estimated at 0.014%. Therefore, universal vaccination against VZV in the elderly is unlikely to reduce dementia risk.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Schmidt SAJ, Veres K, Sørensen HT, et al. Incident Herpes Zoster and Risk of Dementia: A Population-Based Danish Cohort Study. Neurology. 2022. PMID: 35676090. doi:10.1212/WNL.0000000000200709

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。